Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (NASDAQ: SABS) to support the process development and manufacturing of SAB-142, SAB BIO’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results